18F-rhPSMA PET-CT Imaging Performance in Prostate Cancer Patients
20
about 1.8 years
21+
Male only
1 site in CA
What this study is about
This trial is testing the performance of 18F-rhPSMA PET-CT imaging in men with prostate cancer. The goal is to improve the quality of images captured on a specific system used for radiation therapy planning and delivery.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Flotufolastat F-18 Gallium
- 2.Medical Device Usage and Evaluation
- 3.Undergo Computed Tomography
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
flotufolastat (18F)
Primary: Comparison of imaging performance of the [18F]-rhPSMA positron emission tomography (PET)-computed tomography (CT) on the X1 RefleXion Medical Radiotherapy System (RMRS)
imaging